Clinical characteristics and treatment outcomes of women with recurrent uterine leiomyosarcoma
SCS is an important treatment choice for recurrent uLMS and seems to have benefited patients. Time to fist recurrence within 12 months is an independent predictor of decreased 5-year OS in SCS subgroup.
Authors
- Hongwen Yao (ORCID: https://orcid.org/0000-0002-3749-9402)
- Lingying Wu
- Ning Li
- Yaxi Wang (ORCID: https://orcid.org/0009-0002-8919-7155)
- Hua Yuan (ORCID: https://orcid.org/0000-0002-9213-2988)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- National Cancer Center (US)
Publication Details
- Journal
- Orphanet Journal of Rare Diseases
- Published
- 2024-10-25
- DOI
- https://doi.org/10.1186/s13023-024-03415-3
- Citations
- 3
- Primary Topic
- Uterine Myomas and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.75
Funders
- Chinese Academy of Medical Sciences